- Human（1）
No data
- His Tag & Avi Tag（1）
No data
- HEK293（1）
No data
- Biotin-labeled（1）
No data
- RUO（1）
No data
- No（1）
No data
- 25ug/$145.00
- 200ug/$840.00
No data
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| HLA-A*02:01 & B2M | Biotinylated Human HLA-A*02:01&B2M Monomer Protein (Peptide free, MALS verified) |  Human | HEK293 | MALSSDS-PAGE | $145.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Lerapolturev | Phase 2 Clinical | National Cancer Institute, Istari Oncology Inc, Duke University Medical Center | Ependymoma; Medulloblastoma; Solid tumours; Glioblastoma; Oligodendroglioma; Urinary Bladder Neoplasms; Brain Neoplasms; Breast Neoplasms; Gliosarcoma; Astrocytoma; Carcinoma, Embryonal; Glioma; Melanoma | Details | |
| NTX-1088 | Phase 1 Clinical | Nectin Therapeutics Ltd | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |
